Successful Fill & Finish / Containment webinar with Bausch+Ströbel

Containment Webinar with B+S

On September 11th Richard Denk from SKAN and Thomas Bühler from Bausch+Ströbel held an interesting webinar about Innovative Aseptic Processing of Antibody-Drug Conjugates.

With four antibody-drug conjugates (ADC) approved by the U.S. Food and Drug Administration (FDA), the development and manufacturing of targeted ADC therapies has become a booming field. Due to the intrinsic complexity of these drug entities, development and manufacturing of antibody-drug conjugates remains very challenging. Strict containment is required to guarantee the protection and safety of both operators and products.

Register here to watch: Webinar


Meet SKAN's specialists in person at trade fairs and conventions.

Learn More


Videos about products and interviews

Learn More

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.